poloxalene has been researched along with Fascioliasis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baska, P; Bertagnolli da Rosa, L; Dezen, D; Duarte, MMMF; Henker, LC; Januszkiewicz, K; Lucca, NJ; Mendes, RE; Moresco, RN; Norbury, L; Piva, MM; Prior, KC; Schwertz, CI | 1 |
1 other study(ies) available for poloxalene and Fascioliasis
Article | Year |
---|---|
Immune protection conferred by recombinant MRLC (myosin regulatory light chain) antigen in TiterMax GoldĀ® adjuvant against experimental fasciolosis in rats.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Helminth; Antigens, Helminth; Cytokines; Disease Models, Animal; Fascioliasis; Feces; Immunoglobulin G; Male; Myosin Light Chains; Parasite Egg Count; Parasite Load; Poloxalene; Rats, Wistar; Recombinant Proteins; Th1 Cells; Th2 Cells; Vaccines, Synthetic | 2017 |